Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts | Zendy

Laura Mauri | Zendy; Treacy S. Silbaugh | Zendy; Robert Wolf | Zendy; Katya Zelevinsky | Zendy; Ann Lovett | Zendy; Zheng Zhou | Zendy; Frederic S. Resnic | Zendy; SharonLise T. Normand | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts

Author(s) -

Laura Mauri,

Treacy S. Silbaugh,

Robert Wolf,

Katya Zelevinsky,

Ann Lovett,

Zheng Zhou,

Frederic S. Resnic,

SharonLise T. Normand

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.108.781377

Subject(s) - medicine , bare metal , drug , term (time) , coronary stenting , intensive care medicine , cardiology , surgery , stent , restenosis , pharmacology , physics , quantum mechanics

Drug-eluting stents (DES) reduce the need for repeat revascularization, but their long-term safety relative to that of bare-metal stents (BMS) in general use remains uncertain. We sought to compare the clinical outcome of patients treated with DES with that of BMS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research